Stearoylethanolamide (SEA) has been shown to decrease food intake independent of PPAR and without changing hematochemical parameters such as glucose and triglyceride levels or leptin (a hormone involved with satiety) expression.

There is few supplier who can provide SEA, but WASETA developed it very early. And we put some SEA in US warehouse, was sold well.

WASETA has it’s own technology develop department and QC department, focus on new products D&R.

Please be free to contact with WASETA if you need any new ingredients for health.